Hävard Sletta

Title: Hävard Sletta: Innovator in Nystatin Biosynthesis

Introduction

Hävard Sletta is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of biotechnology, particularly in the area of nystatin biosynthesis. His innovative work has led to the development of a patent that showcases his expertise and creativity.

Latest Patents

Hävard Sletta holds a patent titled "Genes encoding a nystatin polyketide synthase and their manipulation and utility." This invention provides a nucleic acid molecule comprising various nucleotide sequences that are crucial for the biosynthesis of nystatin. The patent outlines sequences that can encode or complement a nystatin PKS enzyme, facilitating the synthesis of nystatin derivatives and novel polyketide macrolide structures. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Sletta's career is marked by his work at Sinvent AS, where he has been able to apply his research and development skills in a practical setting. His focus on nystatin and its derivatives has positioned him as a key player in the biotechnology sector. His research has implications for pharmaceutical applications, particularly in the development of new treatments.

Collaborations

Hävard has collaborated with notable colleagues such as Sergey Zotchev and Olga Nikolayivna Sekurova. These collaborations have enhanced his research and contributed to the advancement of knowledge in the field of polyketide biosynthesis.

Conclusion

Hävard Sletta's innovative work in nystatin biosynthesis exemplifies the impact of dedicated research in biotechnology. His patent and collaborations highlight his commitment to advancing the field and developing new therapeutic solutions.